Revolutionary intracellular screening platform enables the discovery of innovative therapeutics that address complex and challenging disease targets.
Vision
Our vision is to transform the lives of patients by applying our innovative technologies to tackle complex and challenging disease targets that are difficult to address using conventional drug discovery methods.
Science
Revolutionary Platform
Our Microcycle® platform allows direct screening for biologically active library members inside mammalian cells and facilitates small molecule hit-to-lead programs.
Pipeline
Challenging cancer targets
We are currently deploying our platform to build a pipeline of first-in-class small molecule drugs to initially address high priority cancer targets that have evaded conventional discovery approaches.
